Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kirk D Jones

Showing results (81-90 of 126) with videos related to

Pageof 13
Sort By:
Thorax|March 20, 2012
Relative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosisLuca Richeldi, Christopher J Ryerson, Joyce S Lee, et al.
Chest|October 12, 2013
Predicting survival across chronic interstitial lung disease: the ILD-GAP modelChristopher J Ryerson, Eric Vittinghoff, Brett Ley, et al.
American Journal of Respiratory Cell and Molecular Biology|October 1, 2016
Persistent Pathology in Influenza-Infected Mouse LungsCindy M Kanegai, Ying Xi, Matthew L Donne, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|April 27, 2010
Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosisHarold R Collard, Carolyn S Calfee, Paul J Wolters, et al.
The Lancet. Respiratory Medicine|June 27, 2017
The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control studyBrett Ley, Chad A Newton, Isabel Arnould, et al.
Respiratory Medicine|August 26, 2015
Survival in interstitial pneumonia with features of autoimmune disease: a comparison of proposed criteriaDeborah Assayag, Eunice J Kim, Brett M Elicker, et al.
The European Respiratory Journal|December 11, 2012
Prevalence and prognosis of unclassifiable interstitial lung diseaseChristopher J Ryerson, Thomas H Urbania, Luca Richeldi, et al.
Respiratory Research|November 22, 2012
Cleaved cytokeratin-18 is a mechanistically informative biomarker in idiopathic pulmonary fibrosisSeung-Ick Cha, Christopher J Ryerson, Joyce S Lee, et al.
Chest|November 7, 2016
Use of Mycophenolate Mofetil or Azathioprine for the Management of Chronic Hypersensitivity PneumonitisJulie Morisset, Kerri A Johannson, Eric Vittinghoff, et al.
Clinical Lung Cancer|June 25, 2017
Adjuvant Chemotherapy Guided by Molecular Profiling and Improved Outcomes in Early Stage, Non-Small-Cell Lung CancerGavitt A Woodard, Sue X Wang, Johannes R Kratz, et al.
Pageof 13

Showing results (81-90 of 126) with videos related to

Sort By:
Pageof 13
Thorax|March 20, 2012
Relative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosisLuca Richeldi, Christopher J Ryerson, Joyce S Lee, et al.
Chest|October 12, 2013
Predicting survival across chronic interstitial lung disease: the ILD-GAP modelChristopher J Ryerson, Eric Vittinghoff, Brett Ley, et al.
American Journal of Respiratory Cell and Molecular Biology|October 1, 2016
Persistent Pathology in Influenza-Infected Mouse LungsCindy M Kanegai, Ying Xi, Matthew L Donne, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|April 27, 2010
Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosisHarold R Collard, Carolyn S Calfee, Paul J Wolters, et al.
The Lancet. Respiratory Medicine|June 27, 2017
The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control studyBrett Ley, Chad A Newton, Isabel Arnould, et al.
Respiratory Medicine|August 26, 2015
Survival in interstitial pneumonia with features of autoimmune disease: a comparison of proposed criteriaDeborah Assayag, Eunice J Kim, Brett M Elicker, et al.
The European Respiratory Journal|December 11, 2012
Prevalence and prognosis of unclassifiable interstitial lung diseaseChristopher J Ryerson, Thomas H Urbania, Luca Richeldi, et al.
Respiratory Research|November 22, 2012
Cleaved cytokeratin-18 is a mechanistically informative biomarker in idiopathic pulmonary fibrosisSeung-Ick Cha, Christopher J Ryerson, Joyce S Lee, et al.
Chest|November 7, 2016
Use of Mycophenolate Mofetil or Azathioprine for the Management of Chronic Hypersensitivity PneumonitisJulie Morisset, Kerri A Johannson, Eric Vittinghoff, et al.
Clinical Lung Cancer|June 25, 2017
Adjuvant Chemotherapy Guided by Molecular Profiling and Improved Outcomes in Early Stage, Non-Small-Cell Lung CancerGavitt A Woodard, Sue X Wang, Johannes R Kratz, et al.
Pageof 13